| NTRA |
Natera, Inc. |
21.08B |
5.84% |
|
|
|
|
|
159.64 |
-1.69% |
55.13% |
34.91% |
|---|
| VCYT |
Veracyte, Inc. |
3.17B |
5.42% |
|
|
|
|
|
40.95 |
-0.56% |
73.63% |
40.04% |
|---|
| QGEN |
Qiagen N.V. |
9.99B |
4.57% |
|
|
|
|
|
45.01 |
-0.11% |
32.79% |
54.43% |
|---|
| TECH |
Bio-Techne Corporation |
11.63B |
4.50% |
|
|
|
|
|
73.22 |
0.25% |
46.40% |
45.47% |
|---|
| BNTX |
BioNTech SE |
27.28B |
4.39% |
|
|
|
|
|
113.77 |
-0.32% |
45.99% |
57.49% |
|---|
| A |
Agilent Technologies, Inc. |
38.79B |
4.37% |
|
|
|
|
|
135.83 |
-0.20% |
25.72% |
19.73% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.43B |
4.21% |
|
|
|
|
|
19.53 |
-0.51% |
62.92% |
55.24% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.38B |
4.18% |
|
|
|
|
|
28.70 |
-0.38% |
57.33% |
69.10% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.77B |
4.07% |
|
|
|
|
|
67.02 |
0.59% |
35.42% |
36.22% |
|---|
| ILMN |
Illumina, Inc. |
21.40B |
4.04% |
|
|
|
|
|
134.96 |
-0.18% |
42.76% |
12.85% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.78B |
4.01% |
|
|
|
|
|
123.37 |
1.21% |
50.94% |
4.26% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.51B |
3.80% |
|
|
|
|
|
41.07 |
0.32% |
52.60% |
1.80% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
31.28B |
3.53% |
|
|
|
|
|
242.50 |
-0.31% |
37.14% |
26.25% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
4.05B |
3.42% |
|
|
|
|
|
43.82 |
0.16% |
76.77% |
43.81% |
|---|
| MRNA |
Moderna, Inc. |
15.56B |
3.22% |
|
|
|
|
|
40.43 |
0.40% |
72.86% |
58.65% |
|---|
| LEGN |
Legend Biotech Corporation |
6.01B |
3.19% |
|
|
|
|
|
32.78 |
-0.06% |
72.59% |
56.22% |
|---|
| TXG |
10x Genomics, Inc. |
1.78B |
2.96% |
|
|
|
|
|
14.67 |
0.00% |
77.18% |
41.28% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.71B |
2.95% |
|
|
|
|
|
31.12 |
-0.73% |
68.25% |
13.87% |
|---|
| 1548.HK |
GENSCRIPT BIOTECH CORP |
|
2.72% |
|
|
|
|
|
|
|
|
|
|---|
| NTLA |
Intellia Therapeutics, Inc. |
1.23B |
2.43% |
|
|
|
|
|
12.12 |
0.58% |
91.69% |
87.27% |
|---|
| MYGN |
Myriad Genetics, Inc. |
1.23B |
2.43% |
|
|
|
|
|
13.50 |
-1.75% |
62.93% |
76.02% |
|---|
| GILD |
Gilead Sciences, Inc. |
117.66B |
2.30% |
|
|
|
|
|
94.41 |
0.49% |
21.75% |
-2.51% |
|---|
| CDNA |
CareDx, Inc |
1.15B |
2.14% |
|
|
|
|
|
21.44 |
0.09% |
111.11% |
30.48% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
1.28B |
1.98% |
|
|
|
|
|
12.02 |
2.91% |
100.67% |
68.48% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
105.75B |
1.86% |
|
|
|
|
|
410.65 |
0.61% |
26.02% |
24.24% |
|---|
| QURE |
uniQure N.V. |
864.22M |
1.56% |
|
|
|
|
|
17.73 |
2.19% |
65.06% |
24.05% |
|---|
| VIR |
Vir Biotechnology, Inc. |
1.02B |
1.32% |
|
|
|
|
|
7.40 |
0.27% |
135.92% |
81.55% |
|---|
| MRVI |
Maravai LifeSciences Holdings, Inc. |
795.74M |
1.25% |
|
|
|
|
|
5.61 |
5.25% |
104.58% |
87.41% |
|---|
| PSTX |
Poseida Therapeutics, Inc. |
926.89M |
1.23% |
|
|
|
|
|
9.51 |
0.21% |
79.04% |
4.92% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
528.56M |
1.01% |
|
|
|
|
|
1.9300 |
-1.03% |
95.14% |
26.46% |
|---|
| SGMO |
Sangamo Therapeutics, Inc. |
548.74M |
0.99% |
|
|
|
|
|
2.6300 |
5.20% |
179.83% |
15.20% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
571.36M |
0.73% |
|
|
|
|
|
18.68 |
0.92% |
48.24% |
69.11% |
|---|
| VERV |
Verve Therapeutics, Inc. |
533.38M |
0.72% |
|
|
|
|
|
6.30 |
9.19% |
122.21% |
32.07% |
|---|
| RGNX |
REGENXBIO Inc. |
389.92M |
0.66% |
|
|
|
|
|
7.87 |
6.35% |
129.02% |
63.99% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
454.99M |
0.58% |
|
|
|
|
|
2.1700 |
3.83% |
105.67% |
57.50% |
|---|
| SANA |
Sana Biotechnology, Inc. |
379.56M |
0.43% |
|
|
|
|
|
1.7000 |
-2.86% |
430.61% |
52.29% |
|---|
| TSVT |
2seventy bio, Inc. |
157.86M |
0.29% |
|
|
|
|
|
3.06 |
0.99% |
152.16% |
20.21% |
|---|
| CRBU |
Caribou Biosciences, Inc. |
153.94M |
0.28% |
|
|
|
|
|
1.7000 |
0.59% |
86.32% |
21.99% |
|---|
| EDIT |
Editas Medicine, Inc. |
101.53M |
0.20% |
|
|
|
|
|
1.2300 |
1.65% |
121.85% |
52.23% |
|---|
| LYEL |
Lyell Immunopharma, Inc. |
189.82M |
0.17% |
|
|
|
|
|
0.6497 |
6.00% |
604.43% |
69.74% |
|---|
| E |
Eni S.p.A. |
42.33B |
0.01% |
|
|
|
|
|
26.61 |
0.04% |
136.28% |
80.68% |
|---|